Frontlight ResearchEarly access
Trial site
Peking University Cancer Hospital and Institute
- 5running trials
- 2closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Lung cancer6 trials
- Colorectal cancer1 trial
- Deep vein thrombosis and pulmonary embolism1 trial
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- Pancreatic cancer1 trial
- Prostate cancer1 trial
- Phase
- Phase 25 trials
- Phase 11 trial
- Status
- Not yet recruiting4 trials
- Completed2 trials
- Recruiting1 trial
- Suspended1 trial
- Lead sponsor
- Peking University Cancer Hospital & Institute5 trials
- Anhui Shi, MD1 trial
- Danatlas Pharmaceuticals Co., Ltd1 trial
- Manuel Monreal1 trial
Running trials
Not yet recruiting
Adebrelimab Maintenance Therapy for LS-SCLC Post Induction Chemo-Adebrelimab Plus CRT or CRT Alone
Not yet recruiting
Adebrelimab Plus Chemoradiotherapy Followed by Adebrelimab Maintenance in Limited-Stage SCLC
Not yet recruiting
Recruiting
Not yet recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer4 recruiting
- Colorectal cancer1 recruiting
- Endometrial cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Pancreatic cancer1 recruiting
- Prostate cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 15 Nov 2026